Fox Christine Ann
Mereo BioPharma Group plc · Chief Financial Officer
Fox Christine Ann is listed in filings as Chief Financial Officer at Mereo BioPharma Group plc. This profile follows SEC Form 4 activity through Feb 2, 2026, including sale activity. Recent filings connect the profile to Mereo BioPharma Group plc (MREO). The current snapshot covers public activity from Jun 25, 2024 to Feb 2, 2026. Reported amounts are shown as $138.9K to $105.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $41k9.1k shares | SellSep 12, 2024 | $4.47 | $0.3146 | |
| $100k29.4k shares | SellJun 26, 2024 | $3.39 | $0.3146 | |
| $48k13k shares | SellJun 25, 2024 | $3.69 | $0.3146 |